CRESCITA THERAPEUTICS INC (CTX.CA) Stock Income Statement
TSX:CTX - Toronto Stock Exchange - CA2258471028 - Common Stock - Currency: CAD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 17.40M | 17.52M | 23.53M | 16.77M | 15.64M | |||
| Cost Of Goods | 7.73M | 7.16M | 10.34M | 7.08M | 4.67M | |||
| Gross Profit | 9.67M | 10.36M | 13.18M | 9.69M | 10.97M | |||
| Operating Expenses | 12.73M | 12.32M | 12.65M | 11.52M | 10.44M | |||
| Research and Development | 708.00K | 699.00K | 610.00K | 630.00K | 1.10M | |||
| Selling, General, and Administrative Expenses | 9.84M | 9.16M | 9.62M | 8.56M | 6.75M | |||
| Operating Income | -3.06M | -1.96M | 530.00K | -1.83M | 530.00K | |||
| Interest Income/Expense | 519.00K | 448.00K | -10.00K | -290.00K | 220.00K | |||
| Other Income/Expense | 0.00 | -22.00K | -120.00K | 0.00 | N/A | |||
| Non Recurring Items | N/A | N/A | N/A | 1.11M | -230.00K | |||
| Income Before Taxes | -2.54M | -1.53M | 400.00K | -1.01M | 520.00K | |||
| Income Tax | 197.00K | 456.00K | -460.00K | 100.00K | 480.00K | |||
| Net Income | -2.74M | -1.99M | 860.00K | -1.11M | 40.00K | |||
| EBITDA | -1.68M | -450.00K | 2.00M | -450.00K | 2.02M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.14 | -0.10 | 0.04 | -0.05 | 0.00 | |||
| Statistics | ||||||||
| Gross Profit Margin | 55.58% | 59.15% | 56.01% | 57.78% | 70.14% | |||
| Profit Margin | -15.73% | -11.33% | 3.65% | -6.62% | 0.26% | |||
| Operating Profit Margin | -17.58% | -11.16% | 2.25% | -10.91% | 3.39% | |||
All data in CAD